7.505

2.39% 0.175

Lifeward Ltd (LFWD)

Overview News Price History Discussions Forecast

Lifeward Ltd stock is traded at $7.505, with a volume of 5,706. It is up +2.39% in the last 24 hours and up +3.52% over the past month. Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.

Previous Close:

$7.33

Open:

$7.41

24h Volume:

5,706

Relative Volume:

0.51

Market Cap:

$21.25M

Revenue:

$20.92M

Net Income/Loss:

$-25.87M

P/E Ratio:

-0.3813

EPS:

-19.6815

Net Cash Flow:

$-15.02M

1W Performance:

+0.74%

1M Performance:

+3.52%

6M Performance:

+47.12%

1Y Performance:

+1.69%

1-Day Range:

$7.41

$7.505

1-Week Range:

$7.19

$7.7044

52-Week Range:

$4.14

$10.56

Lifeward Ltd Stock (LFWD) Company Profile

Name

Lifeward Ltd

Sector

Healthcare (1084)

Industry

Medical Devices (140)

Phone

15082511154

Address

2 CABOT ROAD, HUDSON

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

LFWD's Discussions on Twitter

Compare LFWD vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LFWD Lifeward Ltd	7.505	20.59M	20.92M	-25.87M	-15.02M	-19.68
ABT Abbott Laboratories	115.73	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.00	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.61	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.87	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.91	53.19B	6.30B	1.07B	1.09B	1.8406

Lifeward Ltd Stock (LFWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-25	Initiated	Laidlaw	Buy
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy
May-08-15	Reiterated	Barclays	Equal Weight
Oct-07-14	Initiated	Barclays	Equal Weight

View All

Lifeward Ltd Stock (LFWD) Latest News

08:13 AM

H.C. Wainwright reiterates Lifeward stock rating on revenue growth - Investing.com

08:13 AM

Aug 17, 2026

Lifeward Q2 revenue rises 16% to $6.6 million - grafa.com

Aug 17, 2026

Lifeward Ltd (LFWD)

Lifeward Ltd Stock (LFWD) Company Profile

Compare LFWD vs ABT, SYK, MDT, BSX, EW

Lifeward Ltd Stock (LFWD) Upgrades & Downgrades

Lifeward Ltd Stock (LFWD) Latest News

H.C. Wainwright reiterates Lifeward stock rating on revenue growth - Investing.com

Lifeward Q2 revenue rises 16% to $6.6 million - grafa.com

Lifeward earnings missed by $0.07, revenue topped estimates - Investing.com Canada

Lifeward Ltd. Announces Resignation of Almog Adar from Chief Financial Officer, Effective September 30, 2026 - marketscreener.com

Lifeward Ltd. Announces Stepping Down of Board Members, Effective August 13, 2026 - marketscreener.com

Lifeward Q2 revenue beats estimates; adjusted EPS misses consensus - scanx.trade

Lifeward Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Lifeward Ltd. 2026: Revenue $6.62M, Net income ($11.52M), EPS ($4.12) — 10-Q Summary - TradingView

Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt - Stock Titan

Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings? - GuruFocus

Lifeward: Q2 Earnings Snapshot - kens5.com

Form 8K Lifeward Ltd. For: 14 August By Investing.com - Investing.com Nigeria

Lifeward Ltd Q2 revenue up 16% on higher ReWalk Personal exoskeleton sales - TradingView

Lifeward Revenue Rises 16% to $6.6 Million in Second Quarter 2026 - Quiver Quantitative

Lifeward (LFWD) grows Q2 2026 revenue 16% as net loss deepens on non-cash charges - Stock Titan

Lifeward Reports 16% Second-Quarter Revenue Growth and Strengthened Balance Sheet Amid Commercial Expansion - quiverquant.com

Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth - The Manila Times

Lifeward’s CFO to Depart Sept. 30 as Three Directors Step Down - Stock Titan

Lifeward (LFWD) Advances 1.87% to $7.89, Holding Above Key SupportSafe Entry Stocks - Vinanet

Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside - Yahoo Finance

LFWD Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Share UptickTrough Earnings Signal - Vinanet

Lifeward Ltd expected to post a loss of $1.34 a shareEarnings Preview - TradingView

LFWD Q1 2026 Earnings: Wider-than-Expected Loss Signals Rising Cost and Execution PressuresDividend Earnings Report - Vinanet

Lifeward Ltd. SEC Filing (Aug 11, 2026) - Stock Titan

Oramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock Titan

Lifeward Ltd (LFWD) Stock News Today - TradingKey

Lifeward to report Q2 2026 financial results on August 14, no conference call planned - Pluang

Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Lifeward Out With Q2 Numbers - Baystreet.ca

Lifeward to issue Q2 results before 9:30 a.m. Aug. 14; no call - Stock Titan

Lifeward Ltd. (LFWD) Holds Ground Near $7.28 as Shares Trade Within Narrow RangeBollinger Expansion - dars.gov.et

Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access - Quiver Quantitative

A six-month pilot aims to bring Lifeward's ReWalk 7 to more patients - Stock Titan

LFWD Q2'26 Earnings: revenue estimate is 6.53M USD - TradingView

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton - The Manila Times

Form S-3 Lifeward Ltd. For: 3 August By Investing.com - Investing.com South Africa

LFWD|Lifeward Ltd|Price:7.140|Chg%:-0.080 - TradingKey

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 - Stock Titan

LFWD Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerEarnings Surprise Stocks - Vinanet

Lifeward Ltd (LFWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Lifeward Ltd (LFWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

LFWD|Lifeward Ltd|Price:7.050|Chg%:-0.105 - TradingKey

Lifeward Ltd (LFWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Lifeward Ltd (LFWD) Income Statement - TradingKey

Lifeward Ltd (LFWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Lifeward Ltd. Revenue Breakdown – LS:A12BMB - TradingView

Lifeward Ltd (LFWD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Lifeward Ltd (LFWD) Balance Sheet - TradingKey

Lifeward Ltd (LFWD) Cash Flow - TradingKey

Lifeward Ltd (LFWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Lifeward Ltd Stock (LFWD) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to LFWD